Loading the map…
Private limited company registered in Pinner, classed under “Other human health activities”.
Headline figures
FY to Mar 2025 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
What the numbers say
2 findings from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2024 | 2025 |
|---|---|---|
| Profit after tax | — | |
| Turnover | ||
| Net assets | ||
| Cash | ||
| Employees |
Every figure for all 2 years
“—” means we did not find the figure in a source; it is never filled with an estimate.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2024 | 2025 |
|---|---|---|
| Fixed assets | ||
| Current assets | ||
| Creditors due within a year | ||
| Net current assets | ||
| Net assets | ||
| Ratios | ||
| Current ratioCurrent assets for every £1 owed within a year | ||
| Creditors to assetsEverything owed to creditors as a share of fixed plus current assets | ||
5 balance-sheet lines and 2 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Questions people ask
›What does Elegant Skin Care do?
Private limited company registered in Pinner, classed under “Other human health activities”.
›How much turnover does Elegant Skin Care make?
Answered in the full report
›Is Elegant Skin Care profitable?
Elegant Skin Care's profit isn't public: small companies may file without a profit and loss account.
›How many people work at Elegant Skin Care?
Answered in the full report
›Where is Elegant Skin Care based?
Its registered office is 341 Rayners Lane, Pinner, Greater London, HA5 5EN, in Pinner, Greater London.
›When was Elegant Skin Care founded?
Elegant Skin Care Limited was incorporated on 15 April 2023.
›Is Elegant Skin Care still trading?
The register lists Elegant Skin Care Limited as active.